サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：心臓不整脈モニタリングデバイスの世界市場 (2022年-2028年)：市場予測 (デバイス・用途・エンドユーザー別)・地域的展望・成長の潜在性・市場シェア
市場調査レポート
商品コード
1066315

心臓不整脈モニタリングデバイスの世界市場 (2022年-2028年)：市場予測 (デバイス・用途・エンドユーザー別)・地域的展望・成長の潜在性・市場シェア

Cardiac Arrhythmia Monitoring Devices Market Size By Device, By Application, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 150 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.42円
心臓不整脈モニタリングデバイスの世界市場 (2022年-2028年)：市場予測 (デバイス・用途・エンドユーザー別)・地域的展望・成長の潜在性・市場シェア
出版日: 2022年03月12日
発行: Global Market Insights Inc.
ページ情報: 英文 150 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

心臓不整脈モニタリングデバイスの市場は、医療機器の技術的進歩により、2028年にかけて堅調な成長を示すと予測されています。

テレメトリーやモバイル心臓モニターの普及も予測期間中の市場の発展を促進する見通しです。また、新型コロナウイルス感染症 (COVID-19) の流行による遠隔医療サービスの普及や分散化の進展に伴い、個々の患者に合わせたケアを提供するためのスマートなウェアラブルデバイスの急速な普及も近年の産業の成長を後押ししています。

当レポートでは、世界の心臓不整脈モニタリングデバイスの市場を調査し、市場の定義と概要、COVID-19およびその他の市場影響因子の分析、法規制環境、技術情勢、市場規模の推移・予測、デバイス・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 心臓不整脈モニタリングデバイス産業の考察

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 成長要因
    • 潜在的リスク＆課題
  • 成長の可能性の分析
  • COVID-19：影響分析
  • 規制状況
  • 技術情勢
  • ポーターの分析
  • 競合情勢
  • PESTEL分析

第4章 心臓不整脈モニタリングデバイス市場：デバイス別

  • 主要動向
  • ホルターモニター
  • イベントレコーダー
  • モバイル心臓テレメトリ
  • 埋め込み型心臓モニター
  • 心電図（ECG）モニター
  • その他

第5章 心臓不整脈モニタリングデバイス市場：用途別

  • 主要動向
  • 頻脈
    • 心房性頻脈
    • 心室性頻脈
  • 徐脈
  • 期外収縮
  • その他

第6章 心臓不整脈モニタリングデバイス市場：エンドユーザー別

  • 主要動向
  • 病院・診療所
  • 診断センター
  • 外来手術センター
  • 在宅医療
  • その他

第7章 心臓不整脈モニタリングデバイス市場：地域別

  • 主要動向
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 企業プロファイル

  • 競合ダッシュボード
  • Applied Cardiac Systems
  • AliveCor
  • Biotronik
  • Biotricity
  • GE Healthcare
  • iRhythm Technologies
  • Koninklijke Philips N.V.
  • Medtronic plc.
  • Nihon Kohden Corporation
  • St. Jude Medical(Abbott Laboratories)
  • Spacelabs Healthcare(OSI Systems, Inc.)
  • Welch Allyn(Hillrom Services, Inc.)
図表

Data Tables

  • TABLE 1. Global cardiac arrhythmia monitoring devices market size, 2017 - 2021, (USD Million)
  • TABLE 2. Global cardiac arrhythmia monitoring devices market size, 2022 - 2028, (USD Million)
  • TABLE 3. Global cardiac arrhythmia monitoring devices market size, by device, 2017 - 2021 (USD Million)
  • TABLE 4. Global cardiac arrhythmia monitoring devices market size, by device, 2022 - 2028 (USD Million)
  • TABLE 5. Global cardiac arrhythmia monitoring devices market size, by application, 2017 - 2021 (USD Million)
  • TABLE 6. Global cardiac arrhythmia monitoring devices market size, by application, 2022 - 2028 (USD Million)
  • TABLE 7. Global cardiac arrhythmia monitoring devices market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 8. Global cardiac arrhythmia monitoring devices market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 9. Global cardiac arrhythmia monitoring devices market size, by region, 2017 - 2021 (USD Million)
  • TABLE 10. Global cardiac arrhythmia monitoring devices market size, by region, 2022 - 2028 (USD Million)
  • TABLE 11. Industry impact forces
  • TABLE 12. Holter monitor market size, by region, 2017 - 2021 (USD Million)
  • TABLE 13. Holter monitor market size, by region, 2022 - 2028 (USD Million)
  • TABLE 14. Event recorder market size, by region, 2017 - 2021 (USD Million)
  • TABLE 15. Event recorder market size, by region, 2022 - 2028 (USD Million)
  • TABLE 16. Mobile cardiac telemetry market size, by region, 2017 - 2021 (USD Million)
  • TABLE 17. Mobile cardiac telemetry market size, by region, 2022 - 2028 (USD Million)
  • TABLE 18. Implantable cardiac monitor market size, by region, 2017 - 2021 (USD Million)
  • TABLE 19. Implantable cardiac monitor market size, by region, 2022 - 2028 (USD Million)
  • TABLE 20. Electrocardiogram (ECG) monitor market size, by region, 2017 - 2021 (USD Million)
  • TABLE 21. Electrocardiogram (ECG) monitor market size, by region, 2022 - 2028 (USD Million)
  • TABLE 22. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 23. Others market size, by region, 2022 - 2028 (USD Million)
  • TABLE 24. Tachycardia market size, by region, 2017 - 2021 (USD Million)
  • TABLE 25. Tachycardia market size, by region, 2022 - 2028 (USD Million)
  • TABLE 26. Atrial tachycardia market size, by region, 2017 - 2021 (USD Million)
  • TABLE 27. Atrial tachycardia market size, by region, 2022 - 2028 (USD Million)
  • TABLE 28. Ventricular tachycardia market size, by region, 2017 - 2021 (USD Million)
  • TABLE 29. Ventricular tachycardia market size, by region, 2022 - 2028 (USD Million)
  • TABLE 30. Bradycardia market size, by region, 2017 - 2021 (USD Million)
  • TABLE 31. Bradycardia market size, by region, 2022 - 2028 (USD Million)
  • TABLE 32. Premature contraction market size, by region, 2017 - 2021 (USD Million)
  • TABLE 33. Premature contraction market size, by region, 2022 - 2028 (USD Million)
  • TABLE 34. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 35. Others market size, by region, 2022 - 2028 (USD Million)
  • TABLE 36. Hospitals and clinics market size, by region, 2017 - 2021 (USD Million)
  • TABLE 37. Hospitals and clinics market size, by region, 2022 - 2028 (USD Million)
  • TABLE 38. Diagnostic centers market size, by region, 2017 - 2021 (USD Million)
  • TABLE 39. Diagnostic centers market size, by region, 2022 - 2028 (USD Million)
  • TABLE 40. Ambulatory surgical centers market size, by region, 2017 - 2021 (USD Million)
  • TABLE 41. Ambulatory surgical centers market size, by region, 2022 - 2028 (USD Million)
  • TABLE 42. Homecare settings market size, by region, 2017 - 2021 (USD Million)
  • TABLE 43. Homecare settings market size, by region, 2022 - 2028 (USD Million)
  • TABLE 44. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 45. Others market size, by region, 2022 - 2028 (USD Million)
  • TABLE 46. North America market, by country, 2017 - 2021 (USD Million)
  • TABLE 47. North America market, by country, 2022 - 2028 (USD Million)
  • TABLE 48. North America market, by device, 2017 - 2021 (USD Million)
  • TABLE 49. North America market, by device, 2022 - 2028 (USD Million)
  • TABLE 50. North America market, by application, 2017 - 2021 (USD Million)
  • TABLE 51. North America market, by application, 2022 - 2028 (USD Million)
  • TABLE 52. North America market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 53. North America market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 54. North America market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 55. North America market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 56. U.S. market, by device, 2017 - 2021 (USD Million)
  • TABLE 57. U.S. market, by device, 2022 - 2028 (USD Million)
  • TABLE 58. U.S. market, by application, 2017 - 2021 (USD Million)
  • TABLE 59. U.S. market, by application, 2022 - 2028 (USD Million)
  • TABLE 60. U.S. market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 61. U.S. market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 62. U.S. market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 63. U.S. market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 64. Canada market, by device, 2017 - 2021 (USD Million)
  • TABLE 65. Canada market, by device, 2022 - 2028 (USD Million)
  • TABLE 66. Canada market, by application, 2017 - 2021 (USD Million)
  • TABLE 67. Canada market, by application, 2022 - 2028 (USD Million)
  • TABLE 68. Canada market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 69. Canada market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 70. Canada market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 71. Canada market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 72. Europe market, by country, 2017 - 2021 (USD Million)
  • TABLE 73. Europe market, by country, 2022 - 2028 (USD Million)
  • TABLE 74. Europe market, by device, 2017 - 2021 (USD Million)
  • TABLE 75. Europe market, by device, 2022 - 2028 (USD Million)
  • TABLE 76. Europe market, by application, 2017 - 2021 (USD Million)
  • TABLE 77. Europe market, by application, 2022 - 2028 (USD Million)
  • TABLE 78. Europe market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 79. Europe market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 80. Europe market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 81. Europe market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 82. UK market, by device, 2017 - 2021 (USD Million)
  • TABLE 83. UK market, by device, 2022 - 2028 (USD Million)
  • TABLE 84. UK market, by application, 2017 - 2021 (USD Million)
  • TABLE 85. UK market, by application, 2022 - 2028 (USD Million)
  • TABLE 86. UK market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 87. UK market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 88. UK market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 89. UK market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 90. France market, by device, 2017 - 2021 (USD Million)
  • TABLE 91. France market, by device, 2022 - 2028 (USD Million)
  • TABLE 92. France market, by application, 2017 - 2021 (USD Million)
  • TABLE 93. France market, by application, 2022 - 2028 (USD Million)
  • TABLE 94. France market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 95. France market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 96. France market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 97. France market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 98. Germany market, by device, 2017 - 2021 (USD Million)
  • TABLE 99. Germany market, by device, 2022 - 2028 (USD Million)
  • TABLE 100. Germany market, by application, 2017 - 2021 (USD Million)
  • TABLE 101. Germany market, by application, 2022 - 2028 (USD Million)
  • TABLE 102. Germany market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 103. Germany market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 104. Germany market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 105. Germany market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 106. Spain market, by device, 2017 - 2021 (USD Million)
  • TABLE 107. Spain market, by device, 2022 - 2028 (USD Million)
  • TABLE 108. Spain market, by application, 2017 - 2021 (USD Million)
  • TABLE 109. Spain market, by application, 2022 - 2028 (USD Million)
  • TABLE 110. Spain market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 111. Spain market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 112. Spain market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 113. Spain market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 114. Italy market, by device, 2017 - 2021 (USD Million)
  • TABLE 115. Italy market, by device, 2022 - 2028 (USD Million)
  • TABLE 116. Italy market, by application, 2017 - 2021 (USD Million)
  • TABLE 117. Italy market, by application, 2022 - 2028 (USD Million)
  • TABLE 118. Italy market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 119. Italy market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 120. Italy market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 121. Italy market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 122. Asia Pacific market size, by country, 2017 - 2021 (USD Million)
  • TABLE 123. Asia Pacific market size, by country, 2022 - 2028 (USD Million)
  • TABLE 124. Asia Pacific market, by device, 2017 - 2021 (USD Million)
  • TABLE 125. Asia Pacific market, by device, 2022 - 2028 (USD Million)
  • TABLE 126. Asia Pacific market, by application, 2017 - 2021 (USD Million)
  • TABLE 127. Asia Pacific market, by application, 2022 - 2028 (USD Million)
  • TABLE 128. Asia Pacific market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 129. Asia Pacific market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 130. Asia Pacific market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 131. Asia Pacific market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 132. China market, by device, 2017 - 2021 (USD Million)
  • TABLE 133. China market, by device, 2022 - 2028 (USD Million)
  • TABLE 134. China market, by application, 2017 - 2021 (USD Million)
  • TABLE 135. China market, by application, 2022 - 2028 (USD Million)
  • TABLE 136. China market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 137. China market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 138. China market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 139. China market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 140. Japan market, by device, 2017 - 2021 (USD Million)
  • TABLE 141. Japan market, by device, 2022 - 2028 (USD Million)
  • TABLE 142. Japan market, by application, 2017 - 2021 (USD Million)
  • TABLE 143. Japan market, by application, 2022 - 2028 (USD Million)
  • TABLE 144. Japan market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 145. Japan market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 146. Japan market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 147. Japan market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 148. India market, by device, 2017 - 2021 (USD Million)
  • TABLE 149. India market, by device, 2022 - 2028 (USD Million)
  • TABLE 150. India market, by application, 2017 - 2021 (USD Million)
  • TABLE 151. India market, by application, 2022 - 2028 (USD Million)
  • TABLE 152. India market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 153. India market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 154. India market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 155. India market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 156. South Korea market, by device, 2017 - 2021 (USD Million)
  • TABLE 157. South Korea market, by device, 2022 - 2028 (USD Million)
  • TABLE 158. South Korea market, by application, 2017 - 2021 (USD Million)
  • TABLE 159. South Korea market, by application, 2022 - 2028 (USD Million)
  • TABLE 160. South Korea market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 161. South Korea market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 162. South Korea market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 163. South Korea market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 164. Latin America market size, by country, 2017 - 2021 (USD Million)
  • TABLE 165. Latin America market size, by country, 2022 - 2028 (USD Million)
  • TABLE 166. Latin America market, by device, 2017 - 2021 (USD Million)
  • TABLE 167. Latin America market, by device, 2022 - 2028 (USD Million)
  • TABLE 168. Latin America market, by application, 2017 - 2021 (USD Million)
  • TABLE 169. Latin America market, by application, 2022 - 2028 (USD Million)
  • TABLE 170. Latin America market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 171. Latin America market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 172. Latin America market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 173. Latin America market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 174. Brazil market, by device, 2017 - 2021 (USD Million)
  • TABLE 175. Brazil market, by device, 2022 - 2028 (USD Million)
  • TABLE 176. Brazil market, by application, 2017 - 2021 (USD Million)
  • TABLE 177. Brazil market, by application, 2022 - 2028 (USD Million)
  • TABLE 178. Brazil market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 179. Brazil market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 180. Brazil market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 181. Brazil market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 182. Mexico market, by device, 2017 - 2021 (USD Million)
  • TABLE 183. Mexico market, by device, 2022 - 2028 (USD Million)
  • TABLE 184. Mexico market, by application, 2017 - 2021 (USD Million)
  • TABLE 185. Mexico market, by application, 2022 - 2028 (USD Million)
  • TABLE 186. Mexico market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 187. Mexico market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 188. Mexico market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 189. Mexico market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 190. MEA market size, by country, 2017 - 2021 (USD Million)
  • TABLE 191. MEA market size, by country, 2022 - 2028 (USD Million)
  • TABLE 192. MEA market, by device, 2017 - 2021 (USD Million)
  • TABLE 193. MEA market, by device, 2022 - 2028 (USD Million)
  • TABLE 194. MEA market, by application, 2017 - 2021 (USD Million)
  • TABLE 195. MEA market, by application, 2022 - 2028 (USD Million)
  • TABLE 196. MEA market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 197. MEA market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 198. MEA market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 199. MEA market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 200. Saudi Arabia market, by device, 2017 - 2021 (USD Million)
  • TABLE 201. Saudi Arabia market, by device, 2022 - 2028 (USD Million)
  • TABLE 202. Saudi Arabia market, by application, 2017 - 2021 (USD Million)
  • TABLE 203. Saudi Arabia market, by application, 2022 - 2028 (USD Million)
  • TABLE 204. Saudi Arabia market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 205. Saudi Arabia market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 206. Saudi Arabia market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 207. Saudi Arabia market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 208. South Africa market, by device, 2017 - 2021 (USD Million)
  • TABLE 209. South Africa market, by device, 2022 - 2028 (USD Million)
  • TABLE 210. South Africa market, by application, 2017 - 2021 (USD Million)
  • TABLE 211. South Africa market, by application, 2022 - 2028 (USD Million)
  • TABLE 212. South Africa market, by tachycardia, 2017 - 2021 (USD Million)
  • TABLE 213. South Africa market, by tachycardia, 2022 - 2028 (USD Million)
  • TABLE 214. South Africa market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 215. South Africa market, by end-use, 2022 - 2028 (USD Million)

Charts & Figures

  • FIG. 1 Global cardiac arrhythmia monitoring devices industry 360 degree synopsis
  • FIG. 2 Market estimation and forecast methodology
  • FIG. 3 Industry segmentation
  • FIG. 4 Global cardiac arrhythmia monitoring devices market size, 2017 - 2028 (USD million)
  • FIG. 5 Growth potential analysis, by device
  • FIG. 6 Growth potential analysis, by application
  • FIG. 7 Growth potential analysis, by end-use
  • FIG. 8 Porter's analysis
  • FIG. 9 PESTEL analysis
  • FIG. 10 Key segment trends, by device
  • FIG. 11 Key segment trends, by application
  • FIG. 12 Key segment trends, by end-use
  • FIG. 13 Key regional trends
  • FIG. 14 Competitive dashboard, 2021
目次
Product Code: 2732

The cardiac arrhythmia monitoring devices market is expected to witness sturdy growth by 2028 owing to recent technological advancements in medical devices around the world. Additionally, widespread adoption of telemetry and mobile cardiac monitors is likely to foster market development over the forecast period.

Rapid roll out of smart wearable devices to provide personalized patient care in view of increasing decentralization and adoption of remote healthcare services catalyzed by the COVID-19 pandemic has augmented industry uptake in recent years.

The cardiac arrhythmia monitoring devices market has been segregated on the basis of end-use, device, application, and region. From the device perspective, the market has further been bifurcated into implantable cardiac monitor, ECG (electrocardiogram) monitor, event recorder, mobile cardiac telemetry, Holter monitor, and others (patch).

In 2021, the event recorder sub-segment attained a revenue share of nearly 18% in the market and is slated to grow at a robust pace through the review period. This growth is attributed to the increasing rate of product launches and the rising prevalence of heart-related disorders. Moreover, the ease-of-use and portability of event recorders would boost consumer preference for these devices, which is likely to accelerate segmental growth in the coming time period.

In terms of application, the cardiac arrhythmia monitoring devices market has been classified into premature contraction, tachycardia, bradycardia, and others. In 2021, the premature contraction sub-segment was valued at around USD 300 million and is projected to expand at a significant CAGR through the stipulated timeline. Growing disease prevalence rates and mounting risk of cardiomyopathy are estimated to bolster market development. In addition, high accuracy of advanced devices in disease monitoring is set to fuel segmental growth over 2022-2028.

With respect to end-use, the market has been divided into homecare settings, hospitals and clinics, ambulatory surgical centers, diagnostic centers, and others. The cardiac arrhythmia monitoring devices industry share from the diagnostic centers sub-segment is anticipated to expand at a CAGR of approximately 6.7% over the analysis timeframe owing to growing research activities and improving healthcare infrastructure. Moreover, notable expansion of diagnostic capabilities and the proliferating facility network are slated to propel industry uptake over the forthcoming years.

On the regional front, the Latin America cardiac arrhythmia monitoring devices market is poised to grow at more than 5.9% CAGR through the estimated timeframe due to increasing awareness among patients regarding various cardiac arrhythmia monitoring devices and expanding geriatric population worldwide. In addition, surging penetration of leading companies in the LATAM region and rising incidences of atrial flutter and atrial fibrillation are speculated to drive regional market expansion.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle East & Africa
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Cardiac arrhythmia monitoring devices industry 360 degree synopsis
    • 2.1.1 Business trends
    • 2.1.2 Device trends
    • 2.1.3 Application trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Cardiac Arrhythmia Monitoring Devices Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2028
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Growing prevalence of cardiovascular diseases and expenditure on cardiac health globally
      • 3.3.1.2 Technological advancements and introduction of innovative devices for cardiac rhythm monitoring
      • 3.3.1.3 Increasing adoption of mobile and telemetry cardiac monitors
      • 3.3.1.4 Expanding geriatric population base coupled with growing prevalence of obesity
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 Lack of skilled professionals
      • 3.3.2.2 Negative effects of some cardiac monitoring devices on patients
  • 3.4 Growth potential analysis
    • 3.4.1 By device
    • 3.4.2 By application
    • 3.4.3 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
  • 3.7 Technology landscape
    • 3.7.1 Upcoming technologies
  • 3.8 Porter's analysis
  • 3.9 Competitive landscape, 2021
  • 3.10 PESTEL analysis

Chapter 4 Cardiac Arrhythmia Monitoring Devices Market, By Device

  • 4.1 Key segment trends
  • 4.2 Holter monitor
    • 4.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.3 Event recorder
    • 4.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.4 Mobile cardiac telemetry
    • 4.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.5 Implantable cardiac monitor
    • 4.5.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.6 Electrocardiogram (ECG) monitor
    • 4.6.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.7 Others
    • 4.7.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 5 Cardiac Arrhythmia Monitoring Devices Market, By Application

  • 5.1 Key segment trends
  • 5.2 Tachycardia
    • 5.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 5.2.2 Atrial tachycardia
      • 5.2.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 5.2.3 Ventricular tachycardia
      • 5.2.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.3 Bradycardia
    • 5.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.4 Premature contraction
    • 5.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.5 Others
    • 5.5.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 6 Cardiac Arrhythmia Monitoring Devices Market, By End-use

  • 6.1 Key segment trends
  • 6.2 Hospitals and clinics
    • 6.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.3 Diagnostic centers
    • 6.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.4 Ambulatory surgical centers
    • 6.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.5 Homecare settings
    • 6.5.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.6 Others
    • 6.6.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 7 Cardiac Arrhythmia Monitoring Devices Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2017 - 2028 (USD Mn)
    • 7.2.2 Market size, by device, 2017 - 2028 (USD Mn)
    • 7.2.3 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.2.3.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
    • 7.2.4 Market size, by end-use, 2017 - 2028 (USD Mn)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.2.5.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.2.5.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.2.5.3 Market size, by end-use 2017 - 2028 (USD Mn)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.2.6.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.2.6.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.2.6.3 Market size, by end-use 2017 - 2028 (USD Mn)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2017 - 2028 (USD Mn)
    • 7.3.2 Market size, by device, 2017 - 2028 (USD Mn)
    • 7.3.3 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.3.3.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
    • 7.3.4 Market size, by end-use 2017 - 2028 (USD Mn)
    • 7.3.5 UK
      • 7.3.5.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.3.5.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.3.5.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.3.5.3 Market size, by end-use 2017 - 2028 (USD Mn)
    • 7.3.6 France
      • 7.3.6.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.3.6.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.3.6.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.3.6.3 Market size, by end-use 2017 - 2028 (USD Mn)
    • 7.3.7 Germany
      • 7.3.7.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.3.7.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.3.7.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.3.7.3 Market size, by end-use 2017 - 2028 (USD Mn)
    • 7.3.8 Spain
      • 7.3.8.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.3.8.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.3.8.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.3.8.3 Market size, by end-use 2017 - 2028 (USD Mn)
    • 7.3.9 Italy
      • 7.3.9.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.3.9.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.3.9.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.3.9.3 Market size, by end-use 2017 - 2028 (USD Mn)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2017 - 2028 (USD Mn)
    • 7.4.2 Market size, by device, 2017 - 2028 (USD Mn)
    • 7.4.3 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.4.3.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
    • 7.4.4 Market size, by end-use 2017 - 2028 (USD Mn)
    • 7.4.5 China
      • 7.4.5.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.4.5.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.4.5.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.4.5.3 Market size, by end-use 2017 - 2028 (USD Mn)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.4.6.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.4.6.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.4.6.3 Market size, by end-use 2017 - 2028 (USD Mn)
    • 7.4.7 India
      • 7.4.7.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.4.7.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.4.7.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.4.7.3 Market size, by end-use 2017 - 2028 (USD Mn)
    • 7.4.8 South Korea
      • 7.4.8.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.4.8.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.4.8.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.4.8.3 Market size, by end-use 2017 - 2028 (USD Mn)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2017 - 2028 (USD Mn)
    • 7.5.2 Market size, by device, 2017 - 2028 (USD Mn)
    • 7.5.3 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.5.3.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
    • 7.5.4 Market size, by end-use 2017 - 2028 (USD Mn)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.5.5.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.5.5.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.5.5.3 Market size, by end-use 2017 - 2028 (USD Mn)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.5.6.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.5.6.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.5.6.3 Market size, by end-use 2017 - 2028 (USD Mn)
  • 7.6 Middle East & Africa
    • 7.6.1 Market size, by country, 2017 - 2028 (USD Mn)
    • 7.6.2 Market size, by device, 2017 - 2028 (USD Mn)
    • 7.6.3 Market size, by application, 2017 - 2028 (USD Mn)
      • 7.6.3.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
    • 7.6.4 Market size, by end-use 2017 - 2028 (USD Mn)
    • 7.6.5 Saudi Arabia
      • 7.6.5.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.6.5.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.6.5.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.6.5.3 Market size, by end-use 2017 - 2028 (USD Mn)
    • 7.6.6 South Africa
      • 7.6.6.1 Market size, by device, 2017 - 2028 (USD Mn)
      • 7.6.6.2 Market size, by application, 2017 - 2028 (USD Mn)
        • 7.6.6.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
      • 7.6.6.3 Market size, by end-use 2017 - 2028 (USD Mn)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard, 2021
  • 8.2 Applied Cardiac Systems
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 AliveCor
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Biotronik
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Biotricity
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 GE Healthcare
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 iRhythm Technologies
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 Koninklijke Philips N.V.
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Medtronic plc.
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 Nihon Kohden Corporation
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 St. Jude Medical (Abbott Laboratories)
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 Spacelabs Healthcare (OSI Systems, Inc.)
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 Welch Allyn (Hillrom Services, Inc.)
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis